An acute myocardial infarction, particularly one that is large and transmural, can produce alterations in the topography of both the infarcted and noninfarcted regions of the ventricle. This remodeling can importantly affect the function of the ventricle and the prognosis for survival. In the early period, infarct expansion has been recognized by echocardiography as a lengthening of the noncontractile region. The noninfarcted region also undergoes an important lengthening that is consistent with a secondary volume-overload hypertrophy and that can be progressive. The extent of ventricular enlargement after infarction is related to the magnitude of the initial damage to the myocardium and, although an increase in cavity size tends to restore stroke volume despite a persistently depressed ejection fraction, ventricular dilation has been associated with a reduction in survival. The process of ventricular enlargement can be influenced by three interdependent factors, that is, infarct size, infarct healing, and ventricular wall stresses. A most effective way to prevent or minimize the increase in ventricular size after infarction and the consequent adverse effect on prognosis is to limit the initial insult. Acute reperfusion therapy has been consistently shown to result in a reduction in ventricular volume. The reestablishment of blood flow to the infarcted region, even beyond the time frame for myocyte salvage, has beneficial effects in attenuating ventricular enlargement. The process of scarification can be interfered with during the acute infarct period by the administration of glucocorticosteroids and nonsteroidal antiinflammatory agents, which result in thinner infarcts and greater degrees of infarct expansion. Modification of distending or deforming forces can importantly influence ventricular enlargement. Even short-term augmentations in afterload have deleterious long-term effects on ventricular topography. Conversely, judicious use of nitroglycerin seems to be associated with an attenuation of infarct expansion and long-term improvement in clinical outcome. Long-term therapy with an angiotensin converting enzyme inhibitor can favorably alter the loading conditions on the left ventricle and reduce progressive ventricular enlargement as demonstrated in both experimental and clinical studies. With the former therapy, this attenuation of ventricular enlargement was associated with a prolongation in survival. The long-term clinical consequences of long-term angiotensin converting enzyme inhibitor therapy after myocardial infarction is currently being evaluated. Although studies directed at attenuating left ventricular remodeling after infarction are in the early stages, it does seem that this will be an important area in which future research might improve long-term outcome after infarction. (Circulation 1990;81:1161-1172 Tennant and Wiggers' classic description of regional wall motion changes after acute coronary artery ligation describes "local enfeeblement of contraction" as well as "systolic expansion."1 These observations of local contractile dysfunction
An acute myocardial infarction, particularly one that is large and transmural, can produce alterations in the topography of both the infarcted and noninfarcted regions of the ventricle. This remodeling can importantly affect the function of the ventricle and the prognosis for survival. In the early period, infarct expansion has been recognized by echocardiography as a lengthening of the noncontractile region. The noninfarcted region also undergoes an important lengthening that is consistent with a secondary volume-overload hypertrophy and that can be progressive. The extent of ventricular enlargement after infarction is related to the magnitude of the initial damage to the myocardium and, although an increase in cavity size tends to restore stroke volume despite a persistently depressed ejection fraction, ventricular dilation has been associated with a reduction in survival. The process of ventricular enlargement can be influenced by three interdependent factors, that is, infarct size, infarct healing, and ventricular wall stresses. A most effective way to prevent or minimize the increase in ventricular size after infarction and the consequent adverse effect on prognosis is to limit the initial insult. Acute reperfusion therapy has been consistently shown to result in a reduction in ventricular volume. The reestablishment of blood flow to the infarcted region, even beyond the time frame for myocyte salvage, has beneficial effects in attenuating ventricular enlargement. in the infarct, progressive changes in the noninfarcted regions of the left ventricle contribute to the overall process of chamber enlargement. Clinically, it is well recognized that survivors of myocardial infarctions can demonstrate pronounced cavity enlargement that is not explained by an elevated filling pressure,2325 suggesting that, similar to the experimental model of infarction and of eccentric hypertrophy secondary to volume overload, a shift to the right of the ventricular pressure-volume curve occurs. Linzbach26 has shown that the length of the sarcomere from pathologically enlarged hearts is normal, indicating that the volume increase of the impaired ventricle is a consequence of a rearrangement of the myofibrils across the wall rather than a simple stretching of sarcomeres. It is only relatively recently, however, that the progressive nature of this enlargement, beyond the early convalescent period of the infarct, has been appreciated.27-30 In many instances, early infarct expansion is associated not only with immediate but also with continued (late) cavity enlargement. In evaluating the overall response of ventricular volume to infarction, both the early and late alterations in the infarcted and noninfarcted regions must be considered. Although the predominant early changes occur in the thinning and lengthening of the infarct, dilation and eccentric hypertrophy of the viable region also commence early, and this process can continue long after healing of the infarct.
Ventricular Dilation as an Adaptive Process Ventricular dilation after myocardial infarction can be viewed as a response to dysfunction, and in many respects, its extent reflects the magnitude of the primary damage induced by the infarction. Thus, global contractile performance as assessed by ejec- 47 Myocardial
The prolongation of survival in patients treated with acute reperfusion therapy was initially attributed to a salvaging of myocytes and reduction of impairment of ventricular function. The 18-47% reductions in mortality observed in the large randomized trials of thrombolytic therapy, however, seemed disproportionately large with regard to the modest improvements in ejection fraction that have been associated with the use of thrombolytic therapy.54'55
This relative disparity between the degree of improvement in long-term survival and global left ventricular function suggests that reperfusion therapy offers benefits in addition to those associated with actual salvage of myocardium.54'55
By salvaging a rim of epicardium and thereby reducing the fraction of the infarct that is transmural,56 early reperfusion would be anticipated to reduce infarct expansion. Touchstone et a157 demonstrated that acute infarct patients with infarct expansion despite thrombolytic therapy were likely to have an occluded infarct-related artery. Therefore, reestablishment of flow was required to observe this beneficial effect of thrombolytic therapy.57 Even late coronary artery reperfusion at a time after any possible myocardial salvage, however, has also been shown in animal experiments to reduce the lengthening and thinning of the infarcted region.58-60 In the rat, Hochman and Choo58 showed that reperfusion 2 hours after coronary ligation limited the extent of expansion without influencing infarct size or the transmurality of the infarction. A possible explanation is that the late restoration of flow to the already infarcted zone promotes scar healing that prevents or reduces the expansion process. In one study, collagen content In a study of ventricular enlargement after anterior infarction in which the baseline assessment of ventricular size was conducted 3 weeks after infarction, we found that total occlusion of the infarct-related vessel was an important predictor of further ventricular enlargement at 1 year27 (Figure 4) . This Infarct Healing Infarct expansion occurs within hours after infarction before extensive fibroblast proliferation and collagen deposition, both of which result in a firm scar, have taken place.70'71 During this early period, the infarcted region is particularly vulnerable to distorting forces. Once healed, the scar itself is relatively nondistensible and much more resistant to further deformation.72 As discussed above, both early and late reperfusion favorably limit the deformation of the infarct region during scar formation. In addition to reperfusion, pharmacological therapy with antiinflammatory agents can affect the healing process, and thereby exert an influence on the topographic alterations of the ventricle.
A consistent finding in experimental infarct models is that the administration both of glucocorticosteroids and nonsteroidal antiinflammatory agents during the acute phase of the infarct results in a thinner scar region that is associated with more infarct expansion.73-78 The actual collagen content of the healed infarct in animals receiving antiinflammatory therapy seems to be similar to that of scar tissue of nontreated animals.75 '77,78 The antiinflammatory agents, therefore, can be slowing the time course of healing and allowing ventricular wall tension to act on deformable myocardium for a longer time, rather than altering the ultimate composition of the infarct. The detrimental effect of antiinflammatory agents on ventricular topography can result from their prolongation of the period during which the infarct is extensible and under the influence of deforming forces.
The clinical importance of these experimental findings has been emphasized in a recent study by Jugdutt and Basualto.79 Patients receiving either ibuprofen or indomethacin during the early infarction period demonstrated greater lengthening and thinning of the infarcted region than similar patients not receiving these antiinflammatory compounds. These findings of greater infarct segment length and distortion have important clinical impact because patients treated with indomethacin had a higher prevalence of left ventricular aneurysm formation and symptomatic congestive heart failure during follow-up.79 Interestingly, although glucocorticosteroids and nonsteroidal antiinflammatory agents have been shown to interfere with myocardial infarct scar formation, aspirin has no such effect.74 Therefore, aspirin is clearly preferable as an antiinflammatory agent in early infarction.
Mechanical Forces
Since the classic description of Tennant and Wiggers,' that the interruption of coronary blood flow leads to a local enfeeblement of contraction and systolic bulging, it has been apparent that mechanical forces play an important role in deforming the hypoperfused noncontracting region. Dyskinesis is an important manifestation of this mechanical force that distends the noncontracting myocardium. The elongation and further thinning of the infarcted region that is observed with infarct expansion is an exaggeration of the response to the intracavitary distending forces. Modification of the distending or deforming forces acting on both the necrotic and viable myocardium can be expected to result in both acute and long-term changes in the extent of expansion of the infarct on the overall cavity size of the left ventricle and ultimately on the accompanying hypertrophy.
Experimentally, even transient modest pressure elevation by methoxamine infusion 1-5 hours after coronary artery ligation exacerbated infarct expansion and thinning assessed 1 week after infarction.80 Despite comparable infarct hydroxyproline content, dogs exposed to the augmented afterload demonstrated more distortion of this region. 80 This study suggests that even relatively brief alterations in the loading conditions during the period of scar formation might have long-term implications on ventricular shape and size. Long-term augmentation in afterload produced by aortic banding 3 weeks before coronary artery ligation in rats increased the extent of left ventricular enlargement and infarct thinning.81 In a clinical study, Pierard et a182 demonstrated that infarct expansion was more likely to occur in patients with higher arterial pressure and systemic vascular resistance. It is possible that the earlier observations in patients of a beneficial effect of preventing hypertension during the acute infarct period might be related, in part, to limitation of ventricular deformation. 83 Exercise represents a nonpharmacological mechanism of transiently augmenting wall stress. Forced swimming of normal and even hypertensive rats causes eccentric ventricular hypertrophy with a proimposition, even short-term, of this additional hemodynamic burden of swimming after coronary ligation in rats has been shown to cause greater scar thinning. 85, 86 In another study in the rat infarct model, a more moderate exercise program using daily treadmill activity during the first week of experimental infarction did not result in further distortion of the infarct region. 87 Jugdutt et a188 demonstrated in patients that an exercise program that commenced 15 weeks after infarction and continued for 12 weeks exerted an adverse effect only on survivors of large Q wave anterior myocardial infarctions in whom the percentage of the echocardiographic left ventricular contour that was akinetic or dyskinetic exceeded 18%. In these patients with extensive infarctions, the group that exercised had echocardiographic evidence of deterioration in ventricular function and further distortion of infarct region topography with an increase in the expansion index and thinning ratio ( Figure 1 ) that was not observed in a matched control group. This important study88 illustrates that the hemodynamic stress of a graded exercise program can lead to a further distortion of left ventricular contour in patients with large Q wave infarctions and extensive wall motion abnormalities. This study raises a cautionary note that although exercise after infarction is generally well tolerated, the potential to alter ventricular topography adversely exists in highly selected patients.
Attention has also been focused on the potential benefits of reducing wall stress even in normotensive patients in an effort to favorably alter left ventricular topography after infarction. Flaherty and coworkers89 compared the effects of a combination of intraaortic balloon counterpulsation and intravenous nitroglycerin during the acute phase of infarction with conventional therapy without these interventions. Although the clinical outcomes were similar for both therapeutic groups, patients treated with the ventricular unloading regimen exhibited less echocardiographic evidence of lengthening of the noninfarct segment. Intravenous nitroglycerin, known to have profound dose-dependent acute effects on left ventricular filling pressure, arterial pressure, and regional myocardial blood flow has been shown, both in experimental animals and patients, to be associated with a reduction in infarct size. 90 (2), and at 10 days (3) Figure 6 ).
In this same experimental model of myocardial infarction and ventricular dysfunction, the risk of death during long-term follow-up was exponentially related to the extent of histological damage. Longterm therapy with captopril commencing 14 days after coronary ligation was associated with prolongation of survival. 19 Analysis of subgroups using predefined criteria for histological damage demonstrated that the greatest improvement in survival was observed in the group with moderately sized infarcts (20-40% term therapy.22 These studies in the experimental infarct model emphasized that therapy to alter ventricular remodeling after myocardial infarction can, in fact, influence survival. We postulated that ventricular enlargement and dysfunction might favor the establishment of a positive feedback system whereby increases in systolic and diastolic wall stresses promote further ventricular enlargement that, according to La Place's law, will further augment wall tension.37 Treatment with an ACE inhibitor was initiated to reduce the augmented internal load that the damaged ventricle sustains in an attempt to reduce wall stress and the resultant progressive enlargement. Captopril therapy was associated with both a reduction in arterial pressure as well as left ventricular end-diastolic pressure. In this same long-term infarct model in the rat, Raya and coworkers95 demonstrated that long-term captopril therapy resulted in a lower mean circulatory filling pressure, in part attributed to both an augmentation in venous compliance and a reduction in blood volume.95 These effects on blood volume and venous capacitance produced by long-term captopril therapy were not observed in infarcted animals treated in the long term with equihypotensive doses of hydralazine that did not result in attenuation of ventricular enlargement.95 In contrast to arterial dilators such as hydralazine, ACE inhibition increases venous capacitance and has several additional actions that blunt the neurohumoral response to ventricular dysfunction, alter intrarenal hemodynamics, and promote sodium excretion resulting in reductions of both preload and afterload. (Figure 7) . These results confirmed the animal studies showing that ventricular enlargement can be a progressive process after anterior Q wave infarction and that this process can be attenuated by long-term captopril therapy. In addition to the improvement in the primary ventriculographic end point, captopril treatment was associated with prolonged exercise capacity, particularly in the subgroup with the most distorted ventricles at baseline. 96 Sharpe and coworkers97 broadened the eligibility criteria and studied ventricular enlargement in patients with inferior as well as anterior Q wave infarctions, all with left ventricular baseline dysfunction (ejection fraction, <45%).97 Using serial echocardiographic measurements of left ventricular volumes, they demonstrated that placebo-and furosemide-treated groups had progressive ventricular enlargement that was not observed in patients treated with captopril therapy. 97 These beneficial effects of ACE inhibition therapy in preventing progressive ventricular enlargement after myocardial infarction in experimental animals and patients provided the rationale for the ongoing multicenter clinical trial Survival and Ventricular Enlargement (SAVE). This study is testing the hypothesis that the long-term administration of captopril to survivors of infarction with left ventricular dysfunction (radionuclide ejection fraction, c40%) but without clinical manifestations of heart failure will reduce mortality and prevent deterioration in left ventricular function after infarction.
Summary
The acute and long-term changes in ventricular topography (ventricular remodeling) after myocardial infarction are important processes affecting ventricular function and survival. Therapy to limit infarct size, enhance scar formation, reduce or prevent infarct expansion, and reduce ventricular wall stress can all favorably impact on the topographic changes of the ventricle that has sustained an infarction. Although a great deal of attention has been appropriately focused on the limitation of the initial insult during a myocardial infarction, the more insidious ventricular remodeling can also have an important impact on the ultimate outcome after infarction. We believe that efforts to affect left ventricular remodeling are at an early stage of development and that further basic and clinical research in this field will improve the long-term outcome of patients who suffer acute myocardial infarction. 
